Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS)
CNY 28.51
(-2.16%)
CNY 28.51
(-2.16%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -883.23 Million CNY | 6.1% |
| 2022 | -940.62 Million CNY | 41.71% |
| 2021 | -1.61 Billion CNY | 9.24% |
| 2020 | -1.77 Billion CNY | -99.6% |
| 2019 | -890.85 Million CNY | -340.91% |
| 2018 | -202.04 Million CNY | 36.38% |
| 2017 | -317.57 Million CNY | -122.6% |
| 2016 | -142.66 Million CNY | 75.21% |
| 2015 | -575.58 Million CNY | -9.32% |
| 2014 | -526.52 Million CNY | 22.87% |
| 2013 | -682.63 Million CNY | 8.72% |
| 2012 | -747.89 Million CNY | -29.93% |
| 2011 | -575.61 Million CNY | -28.49% |
| 2010 | -447.99 Million CNY | -144.24% |
| 2009 | -183.42 Million CNY | -685.59% |
| 2008 | -23.34 Million CNY | -295.0% |
| 2007 | -5.91 Million CNY | 57.0% |
| 2006 | -13.74 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -475.82 Million CNY | 14.78% |
| 2024 Q1 | -577.95 Million CNY | 34.56% |
| 2024 Q2 | -558.33 Million CNY | 3.39% |
| 2023 Q1 | -1.38 Billion CNY | -47.31% |
| 2023 FY | -883.23 Million CNY | 6.1% |
| 2023 Q4 | -883.23 Million CNY | 23.73% |
| 2023 Q3 | -1.15 Billion CNY | -13.37% |
| 2023 Q2 | -1.02 Billion CNY | 26.28% |
| 2022 Q1 | -1.5 Billion CNY | 6.46% |
| 2022 Q2 | -1.08 Billion CNY | 28.43% |
| 2022 Q4 | -940.62 Million CNY | 31.25% |
| 2022 Q3 | -1.36 Billion CNY | -26.65% |
| 2022 FY | -940.62 Million CNY | 41.71% |
| 2021 Q2 | -1.53 Billion CNY | 30.25% |
| 2021 Q1 | -2.19 Billion CNY | -23.47% |
| 2021 Q3 | -1.55 Billion CNY | -1.43% |
| 2021 Q4 | -1.61 Billion CNY | -3.91% |
| 2021 FY | -1.61 Billion CNY | 9.24% |
| 2020 Q4 | -1.77 Billion CNY | 24.1% |
| 2020 Q3 | -2.34 Billion CNY | -185.21% |
| 2020 Q2 | -821.43 Million CNY | -1.58% |
| 2020 Q1 | -808.62 Million CNY | 9.23% |
| 2020 FY | -1.77 Billion CNY | -99.6% |
| 2019 Q2 | -1.41 Billion CNY | -790.65% |
| 2019 FY | -890.85 Million CNY | -340.91% |
| 2019 Q4 | -890.85 Million CNY | 0.0% |
| 2019 Q1 | 204.68 Million CNY | 0.0% |
| 2018 FY | -202.04 Million CNY | 36.38% |
| 2017 FY | -317.57 Million CNY | -122.6% |
| 2016 FY | -142.66 Million CNY | 75.21% |
| 2015 FY | -575.58 Million CNY | -9.32% |
| 2014 FY | -526.52 Million CNY | 22.87% |
| 2013 Q1 | -728.06 Million CNY | 2.65% |
| 2013 Q3 | -739.82 Million CNY | -5.8% |
| 2013 FY | -682.63 Million CNY | 8.72% |
| 2013 Q2 | -699.23 Million CNY | 3.96% |
| 2012 Q3 | -686 Million CNY | 0.0% |
| 2012 Q1 | -606.05 Million CNY | -5.29% |
| 2012 Q4 | -747.89 Million CNY | -9.02% |
| 2012 FY | -747.89 Million CNY | -29.93% |
| 2011 Q2 | -491.38 Million CNY | -5.28% |
| 2011 FY | -575.61 Million CNY | -28.49% |
| 2011 Q4 | -575.61 Million CNY | -7.78% |
| 2011 Q3 | -534.05 Million CNY | -8.68% |
| 2011 Q1 | -466.72 Million CNY | -4.18% |
| 2010 Q4 | -447.99 Million CNY | -28.24% |
| 2010 FY | -447.99 Million CNY | -144.24% |
| 2010 Q3 | -349.33 Million CNY | 0.0% |
| 2009 FY | -183.42 Million CNY | -685.59% |
| 2008 FY | -23.34 Million CNY | -295.0% |
| 2007 FY | -5.91 Million CNY | 57.0% |
| 2006 FY | -13.74 Million CNY | 0.0% |